NVMI insider plans Rule 144 sale of 3,046 shares

Nova Measuring Instruments (symbol NVMI) filed a notice of proposed insider share sales under Rule 144.

Rhea-AI Filing Summary

Nova Measuring Instruments (symbol NVMI) filed a notice of proposed insider share sales under Rule 144. The filing covers 3,046 ordinary shares to be sold through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of 1351692.96.

The seller previously acquired ordinary shares from the issuer via restricted stock units (RSUs) on several dates between 09/01/2021 and 09/01/2024, in amounts of 7,000, 4,875, 3,375 and 766 shares. The filing notes 31,780,111 ordinary shares outstanding and includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NVMI Rule 144 filing disclose about planned share sales?

The filing discloses an intended sale of 3,046 NVMI ordinary shares. These shares are planned to be sold through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of about 1351692.96 as stated in the document.

How many Nova Measuring Instruments (NVMI) shares are outstanding in this filing?

The document states that 31,780,111 NVMI ordinary shares are outstanding. This figure provides context for the planned Rule 144 sale of 3,046 shares, showing the sale represents a very small portion of the total share count.

How were the NVMI shares in the Rule 144 notice originally acquired?

The shares listed in the Rule 144 notice were acquired via restricted stock units (RSUs) granted by the issuer. RSU acquisition dates include 09/01/2021, 09/01/2022, 09/01/2023 and 09/01/2024, with grants ranging from 766 to 7,000 ordinary shares.

When is the approximate sale date for the NVMI shares under this Rule 144 notice?

The approximate sale date for the 3,046 NVMI ordinary shares is listed as 02/17/2026. This date represents when the broker may execute sales on Nasdaq, subject to market conditions and Rule 144 requirements described in the filing.

Which broker will handle the NVMI Rule 144 share sale?

The Rule 144 notice identifies Oppenheimer & Co. Inc. as the broker. Its address is given as 85 Broad St., New York, NY 10004, and it will handle sales of 3,046 NVMI ordinary shares on Nasdaq according to the filing.

What representation does the seller make in the NVMI Rule 144 notice?

The seller represents that they do not know any material adverse information about NVMI’s current or prospective operations that has not been publicly disclosed. This representation is a standard attestation included in Rule 144 notices for planned insider share sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:40 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001959933
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NOVA LTD.
SEC File Number	000-30668
Address of Issuer	5 DAVID FIKES STREET REHOVOT ISRAEL 7610201
Phone	972-73-229-5600
Name of Person for Whose Account the Securities are To Be Sold	Wilson Adrian Stuart
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc, 85 Broad St. New York NY 10004	3046	1351692.96	31780111	02/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	09/01/2021	RSU	Issuer			7000	09/01/2021	N/A
Ordinary	09/01/2022	RSU	Issuer			4875	09/01/2022	N/A
Ordinary	09/01/2023	RSU	Issuer			3375	09/01/2023	N/A
Ordinary	09/01/2024	RSU	Issuer			766	09/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 11/12/2025
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Adrian Wilson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)